HOOK - Hookipa Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $25.38. This is a potential upside of $24.33 (2317.14%) from yesterday's end of day stock price of $1.05.

Hookipa Pharma's activity chart (see below) currently has 38 price targets and 39 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.46% with an average time for these price targets to be met of 230.75 days.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 20-Dec-2024. First documented stock forecast 13-May-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 20-Dec-2024

$2

$0.95 (90.48%)

1 years 1 months 18 days ago
(20-Dec-2024)

1/6 (16.67%)

$-0.02 (-0.99%)

4

Buy Since 30-Nov-2020

$7

$5.95 (566.67%)

$23

1 years 2 months 17 days ago
(21-Nov-2024)

2/4 (50%)

$4.7 (204.35%)

381

Buy Since 11-Nov-2021

$23

$21.95 (2090.48%)

$11

1 years 6 months 12 days ago
(26-Jul-2024)

1/2 (50%)

$16.85 (273.98%)

375

Buy Since 12-Nov-2021

$80

2 years 5 months 27 days ago
(11-Aug-2023)

0/2 (0%)

$60 (300.00%)

Hold Since 05-Jun-2023

$22.5

$21.45 (2042.86%)

$60

2 years 8 months 2 days ago
(05-Jun-2023)

2/4 (50%)

$10.9 (93.97%)

98

Show more analysts

Please expand the browser size to see the chart

What is HOOK (Hookipa Pharma) average time for price targets to be met?

On average it took 230.75 days on average for the stock forecasts to be realized with a an average price target met ratio 36.46

Which analyst has the current highest performing score on HOOK (Hookipa Pharma) with a proven track record?

ROY BUCHANAN

Which analyst has the current lower performing score on HOOK (Hookipa Pharma) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on HOOK (Hookipa Pharma)?

Roy Buchanan works at JMP and has 2 price targets and 1 ratings on HOOK

Which analyst is the currently most bullish on HOOK (Hookipa Pharma)?

Ying Huang with highest potential upside - $138.95

Which analyst is the currently most reserved on HOOK (Hookipa Pharma)?

Swayampakula Ramakanth with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?